The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
ACTIV-3/TICO Study Group, Angela J. Rogers, Deborah N. Wentworth, Andrew N. Phillips et autres
BACKGROUND: Levels of plasma SARS-CoV-2 nucleocapsid (N) antigen may be an important biomarker in patients with COVID-19 and enhance our understanding of the pathogenesis of COVID-19. OBJECTIVE: To evaluate whether levels of plasma antigen can predict short-term clinical outcomes and identify clinical …
us, gb, au, Ouganda, es, dk (code pays fourni par la source)
63 citations
Annals of Internal Medicine